Health catalyst announces ~$5 million stock repurchase

Salt lake city , march 11, 2025 /prnewswire/ -- health catalyst, inc. ("health catalyst," nasdaq: hcat), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has repurchased shares of its common stock ("common stock") in an aggregate amount of approximately $5 million. these repurchased shares were acquired between march 3, 2025, and march 10, 2025, as part of health catalyst's existing share repurchase program approved by its board of directors on august 2, 2022, which authorized repurchases of up to $40 million of common stock.
HCAT Ratings Summary
HCAT Quant Ranking